loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Rilpivirine Hydrochloride

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Rilpivirine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,686Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NICE says yes to GSK's Cabenuva, new option for HIV patients
    NICE says yes to GSK's Cabenuva, new option for HIV patients

    19 Nov 2021

    // K. Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/nice-gives-a-thumbs-up-to-gsk-s-cabenuva-giving-hiv-patients-attractive-treatment-option

    K. Dunleavy FIERCEPHARMA
    19 Nov 2021
    Share Share
    ViiV sees first global approval of Cabenuva in Canada
    ViiV sees first global approval of Cabenuva in Canada

    23 Mar 2020

    // Anna Smith PHARMATIMES

    http://www.pharmatimes.com/news/viiv_sees_first_global_approval_of_cabenuva_in_canada_1329795

    Anna Smith PHARMATIMES
    23 Mar 2020
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets
    FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets

    07 Jan 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-odefsey-208351-emtricitabine-rilpivirine-hydrochloride-and-tenofovir-alafenamide-fumarate-tablets-1578398200.pdf

    FDA
    07 Jan 2020
    Share Share
    FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues
    FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues

    24 Dec 2019

    // Amber Tong ENDPTS

    https://endpts.com/fda-slams-gsks-monthly-hiv-injectable-with-crl-citing-manufacturing-issues/

    Amber Tong ENDPTS
    24 Dec 2019
    Share Share
    J&J-backed AIDS film picked up by Verizon Media
    J&J-backed AIDS film picked up by Verizon Media

    10 May 2019

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/j-j-sponsored-film-about-first-aids-ward-san-francisco-picked-up-for-broader-distribution

    Beth Snyder Bulik FIERCE PHARMA
    10 May 2019
    Share Share
    Prescription med: new or extended uses, new combinations of registered medicines
    Prescription med: new or extended uses, new combinations of registered medicines

    09 Jul 2018

    // TGA

    https://www.tga.gov.au/prescription-medicines-new-or-extended-uses-registered-medicines

    TGA
    09 Jul 2018
    Share Share